Condition
Spondyloarthropathies
Total Trials
6
Recruiting
1
Active
1
Completed
5
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
20%
1 of 5 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 3 (1)
Trial Status
Completed5
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT06688929CompletedPrimary
Psychosocial and Functional Factors in AxSpA
NCT06369324Not ApplicableCompletedPrimary
Efficacy of Pain Neuroscience Education and Physiotherapy in Patients Diagnosed with Spondyloarthritis
NCT03839862RecruitingPrimary
Faecal Analyses in Spondyloarthritis Therapy
NCT03327454Completed
Benepali® PEN Patient Satisfaction Survey
NCT01087762Phase 3CompletedPrimary
Certolizumab Pegol in Subjects With Active Axial Spondyloarthritis
NCT00768950CompletedPrimary
The Characterization of Small Bowel and Colonic Involvement in Patients With Seronegative Spondyloarthritides
Showing all 6 trials